ABOUT THE FORUM

Since the recent reform of China’s drug approval process, clinical trials and new drug approval in China has speeded up. In 2017 alone, 34 pharma products and 5 biotech products were approved, making a record high in the history. It opened door for drug development companies around the world to the Chinese market and also ignited license-in interest from Chinese public pharma companies.

China Focus@BWB is bringing together investors and pharma leaders from China and healthcare innovators for an exclusive event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations from around the world. The forum features premier 1-to-1 networking opportunities prior and during the forum.

WHY ATTENDING

Learn

Learn about the rising healthcare market opportunity, innovation and investment trend in China from industrial leaders from China

Present

Present in front of 50+ Chinese investors who are actively seeking investment and in-licensing opportunities

Connect

Connect with investors prior to and during the Forum through online pitch and 1-to-1 meetings

Inspire

Sharpen your vision for 2019 with additional opportunity from across the pacific

INDUSTRIES OF FOCUS

Immunotherapy

PD-(L)1

CAR-T

TCR-T

Tumor Vaccine

Oncolytic Virus

end

 

Gene Therapy and Genetic Test

 

Rare Disease Gene Therapy

CRISPA

Genetic Test

 

 

 

AI in Pharma and Healthcare

 

Diagnostics

New drug development

 

 

end

Participating Chinese Companies

Kelun Pharma

 

Livzon Mabpharm

 

Qilu Pharmaceutical Ltd

 

Chia Tai Tianqing

 

GenFleet Therapeutics

 

CARsgen Therapeutics

 

qilu cell therapy

 

Fosun Pharma

 

Hengrui Therapeutics Inc

 

Accelerate NY Seed Fund

 

Delos Capital

 

Sequoia Capital China

 

F-Prime Capital Partners

 

Lilly Asia Venture

 

Ankebio

 

Sino Pharm

 

XtalPi

 

Shanghai Junshi Biosciences

 

Wuxi Apptec

 

Ascletis Pharmaceuticals

 

Kaitai Capital

 

Leking Wellness

 

Haiyao

 

Lee's Pharmaceutical Holdings Ltd.

 

Livzon Pharmaceutical Group

 

Luye Pharma

 

SanBao Group Co. Ltd.

 

3SBio Inc.

 

Hrain Biotechnology

 

Yuyan Bio

 

Wuhan Bio-Raid Biotechnology Co., Ltd

 

Cellular Biomedicine Group

 

Simcere Pharmaceutical Group

 

Xiangxue Group

 

Yabao Pharmaceutical Group Co. Ltd.

 

JW Therapeutics (Shanghai) Co. Ltd.

 

Kelun Phamacetical

 

Eddingpharm Inc.

 

Galaxy Biopharma

 

Unicar-Therapy Biomedicine

 

Oriza Holdings

 

Yuanming Capital

 

AVIC Capital Co., Ltd.

 

Jolly Pharmaceutical

 

Guest speaker

Zonghai Li

CEO&CSO, CARsgen Therapeutics

Zhaolong Gong

CEO, 3D Medcare

Qiang Lu

Chairman, Genfleet Pharmaceutical

Lynn Yang

Managing Director, Sequoia Capital China

Ai-Min Hui (TBD)

CMO, Fosun Pharma

John Chen

Director of Business Development, Livzon Mabpharm, Inc

Rebecca Robbins

Business Reporter, STAT News

Anjiang (Vincent) Liu

Senior Advisor, Fosun Pharma

Yuanhua Ding

Head of External R&D Innovation – Asia, Pfizer Worldwide Research & Development

Noel Goddard

Principal, Accelerate NY Seed Fund

Kim Nearing

Managing Director, Cedrus Group

Bob Ai

Senior Vice President , Solebury Trout

Chong Xu

Senior Associate, F-Prime Capital Partners

Tim Xiao

Principal at Delos Capital

Ginger Ding

Director of Research, MyBioGate

Feng Tian

Chief scientific Officer, Ambrx

Jinming Gu

Head of Biologics Development at Abpro labs;
Former Executive Director of Biologics Discovery at Shanghai HengRui Pharmaceuticals

Zhenhua Wu

CEO, NeuExcell Therapeutics

Miguel Forte

CEO, Zelluna Immunotherapy;
Chair, Commercialization Committee at ISCT

Stefanos Theoharis

SVP Corporate Development and Partnering, Cell Medica

Zonghai Li

CEO&CSO, CARsgen Therapeutics

Zhinan Xia

Founder and CSO, Abimmune Bio
Previous Director, Synageva BioPharma Corp.

Presentation, direct introduction, facilitated meetings and more.

Why Present

Increase your company’s visibility and generate interest among over 50 active BD executives from top Chinese pharma and investment firms
Get direct introduction to potential partners
Get feedback from Chinese investors, frame your strategy with the growing China market

What’s included for presenting companies

10-minute company presentation slot with PowerPoint slides
Be Featured in partnering system
Direct introduction to at least 5 top-tier VCs, pharma and private equity investors prior to the Forum
Facilitated partnering meetings 1-to-1 consultation to help you short-list potential partners, make direct introductions and arrange meetings. Secure at least 10 meetings
Full list of Chinese attendees and their contact information

Apply to Present

Sept 4th 10:00-12:00 Registration
1:30-5:00 Opening Remarks
Keynote: New Drugs to Enter  China under CFDA Reform: Opportunities and Challenges

Dr. Ruyi He, Chief Scientist, Center for Drug Evaluation, CFDA

Keynote: China Innovation in Immunotherapy
Panel Discussion: Chinese Big Pharma’s strategy in Drug Development and Commercialization Collaboration
Panel Discussion: Cross-border Investment and Collaboration under the US-China Trade Friction
Sept 5th 8:00 - 10:00 1-to-1 partnering meetings
10:00 -12:00 pm Technical Track: Sector Spotlight, Industry Map and Company Pitch

  • CAR-T and TCR-T
12:00 pm - 1:30 pm Lunch Break and 1-to-1 partnering meetings
1:30 pm - 5:00 pm Technical Track: Sector Spotlight, Industry Map and Company Pitch

  • PD-(L)1 Combined Therapies
  • Gene Therapy for Rare Disease
5:00 pm - 6:00 pm 1-to-1 partnering meetings
Sept 6th 8:00 - 5:00 pm 1-to-1 partnering meetings
Sept 7th   VIP Meetings

EVENT VENUE

Hynes Convention Center, Room 102

900 Boylston St
Boston, MA 02115

Badge Collection

The registration desk is located in the Main Lobby of the Hynes Convention Centre on the Plaza Level. You will receive an email with a bar code of your ticket. To expedite your registration check-in process, please print this barcode confirmation or bring it on your mobile device with you.

Registration Hours

Tuesday, September 4 – 8:00 am to 5:00 pm

Wednesday, September 5 - 7:30 am to 7:30 pm

Thursday, September 6 -  7:00 am to 5:30 pm

REGISTER NOW

China Focus@BWB Forum, including:

  • One account to our 1-to-1 meeting system, access to sending 1-to-1 meetings to all attendees
  • Forum access to September 4-6

Early Bird(Before July 31):$349

Regular Price(August 1 to September 4):$499

REGISTER NOW

China Focus@BWB Forum, including:

Registration Detail Early Bird

(Before July 31)

Regular
China Focus@BWB Includes:

A partnering system account

Access to all forum session of China Focus@BWB

$349 $499
BWB All Access Pass Includes China Focus@BWB and access to the following events:

BioProcess International Conference & Exhibition

Cell & Gene Therapy Bioprocessing & Commercialization

Microbiome Therapeutics US

Al Applications for Drug Discovery and Development

Cell & Gene Connect

BioPharma America

$4,199

 

Agenda

Sept 4th

10:00-12:00

  • Registration

1:30-5:00

  • Opening Remarks
    • Keynote: China’s FDA reform – Opportunities for Novel Drugs to Enter China
    • Keynote: China Innovation in Immunotherapy
    • Panel Discussion: Chinese Big Pharma’s strategy in Drug Development and Commercialization Collaboration
    • Panel Discussion: Cross-border Investment and Collaboration under the US-China Trade Friction

Sept 5th

8:00 am – 10:00 am

  • 1-to-1 partnering meetings

10:00 am -12:00 pm

  • Technical Track: Sector Spotlight, Industry Map and Company Pitch
    • CAR-T and TCR-T

12:00 pm – 1:30 pm

  • Lunch Break and 1-to-1 partnering meetings

1:30 pm – 5:00 pm

  • Technical Track: Sector Spotlight, Industry Map and Company Pitch
    • PD-(L)1 Combined Therapies
    • Gene Therapy for Rare Disease

5:00 pm – 6:00 pm

  • 1-to-1 partnering meetings

Sept 6th

8:00 – 5:00 pm

  • 1-to-1 partnering meetings

Sept 7th

  • VIP Meetings

Platinum sponsorship

Troutman Sanders LLP

 

Partners

CONTACT US

Sponsorship

 

Xinxin Li

Phone:+1-713-814-5022

Email:xinxin.li@mybiogate.com

Registration

 

Feifan Zheng

Phone:+1-713-814-5022

Email:feifan.zheng@mybiogate.com